Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 605 of 6351
-
Can a common diabetes drug reshape blood health in PCOS?
Disease control CompletedThis double-blind, placebo-controlled, parallel-group randomized controlled trial evaluated changes in metabolic, vitamin B12, iron-status, erythropoietic, and hematological parameters among women with polycystic ovary syndrome (PCOS) receiving metformin therapy. Women aged 18-4…
Phase 4 • Sponsor: Jerash Private University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
AI reads your Heart's future: new study aims to predict heart attacks from simple ECG
Diagnosis OngoingThe goal of this observational study is to develop and validate an artificial intelligence(AI)-based prediction model for new-onset acute myocardial infarction(AMI) using electrocardiogram(ECG) data. The main question it aims to answer is whether the AI-based ECG accurately forec…
Sponsor: Guangdong Provincial People's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
New hope for rare cancer: drug cocktail targets stubborn LCH
Disease control OngoingIn adult patients with relapsed/refractory Langerhans cell histiocytosis (LCH), a treatment regimen of XTD regimen (Selinexor, Thalidomide and Dexamethasone) is planned to be used.
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Promising drug combo aims to wipe out bladder cancer before surgery
Disease control Recruiting nowThis is a single arm, open-label, multicenter phase II clinical study to evaluate the safety and efficacy of 9MW2821 combined with Toripalimab in perioperative patients with urothelial cancer.
Phase 2 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
AI reads CT scans to spot stomach cancer stage with precision
Diagnosis Recruiting nowAccurate preoperative assessment of gastric cancer stage guides eligibility for endoscopic resection, extent of gastrectomy and lymphadenectomy, selection for neoadjuvant therapy, and use of staging laparoscopy. Contrast-enhanced CT (CECT) is guideline-endorsed for initial stagin…
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
Shorter light therapy may be just as good for treating bulging corneas
Disease control Recruiting nowThe goal of this clinical trial is to study the effects of an experimental (not Food and Drug Administration (FDA)-approved) treatment called corneal crosslinking (CXL) for conditions in which the cornea becomes progressively thin, steep, and misshapen, causing vision to be blurr…
Phase 3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New RSV shot shows promise in protecting babies
Prevention CompletedA multicenter, retrospective cohort study based on clinical data from seven tertiary hospitals in China will be undertaken. The study aims to evaluate the real-world effectiveness of Nirsevimab in preventing Respiratory Syncytial Virus (RSV) infections and all-cause respiratory i…
Sponsor: Han Tongyan • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
New drug cocktail aims to prevent kidney cancer recurrence in High-Risk patients
Disease control OngoingThis study is testing a new treatment approach for people who have had surgery to remove a type of kidney cancer called non-clear cell renal cell carcinoma (non-ccRCC). This kind of kidney cancer is different from the most common type and tends to come back after surgery, especia…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a milk protein shield kidneys from diabetes damage?
Disease control Recruiting nowMultiple pathways and mediators, including oxidative stress, inflammation, and the over-activity of the renin-angiotensin-aldosterone system are involved in the development of albuminuria and progression of diabetic nephropathy (DN), of which oxidative stress is the most prominen…
Phase 2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Breath test meets x-ray: a new way to pinpoint gut troubles?
Diagnosis CompletedHydrogen (H₂) breath tests serve several purposes. (i) detect malabsorption of carbohydrates such as lactose and fructose, (ii) measurement of oro-caecal transit time (iii) associate hydrogen production with the onset of abdominal symptoms like bloating, flatulence, pain, and dia…
Sponsor: Klinik Arlesheim • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
New hope for hard-to-treat prostate cancer: targeted drug enters phase 2 trial
Disease control Recruiting nowThe researchers are doing this study to find out whether tarlatamab is an effective treatment for Delta-like Protein 3 (DLL3)-positive prostate cancer that has spread to other parts of your body (metastasized) and has either come back after treatment (relapsed) or not responded t…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for rare liver disease: experimental drug GS-4321 enters human trials
Disease control Recruiting nowThe goals of this clinical study are to first learn more about safety and dosing of the study drug GS-4321 in healthy participants. The study will then learn about the safety and effectiveness of GS-4321 in participants with chronic hepatitis delta (CHD). The primary objective o…
Phase 1/2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New combo therapy aims to shrink kidney tumors before surgery
Disease control Recruiting nowThis is a phase II study to determine the efficacy and safety of Super-selective tumor artery embolization combined with toripalimab and axitinib as treatment for patients with the advanced kidney cancer . Further evaluate whether the treatment plan is beneficial to the patient's…
Phase 2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:40 UTC
-
New pill could help kids with severe hair loss regrow hair
Disease control OngoingThe purpose of this study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the possible treatment of severe alopecia areata. Alopecia areata is a condition that causes hair loss. This study is seeking participants who have: * at least 50%…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New RSV shield for infants: Real-World study launches
Prevention OngoingThe purpose of this study is to describe the safety and efficacy outcomes associated with the use of nirsevimab, administered as per routine clinical practice, in neonates and infants aged 0 to 12 months born during or entering their first RSV season and in children up to 24 mont…
Phase 4 • Sponsor: Sanofi • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
New Dual-Targeting CAR-T therapy enters human trials for bone marrow cancer
Disease control Recruiting nowThis is an interventional, modular, open-label, multicenter study to primarily evaluate the safety and tolerability of AZD0120 in adult participants with multiple myeloma (MM).
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for tough lymphoma: drug combo plus stem cell transplant shows promise
Disease control Recruiting nowThis phase II trial tests how well epcoritamab in combination with standard of care (SOC) platinum-based chemotherapy (rituximab, ifosfamide, carboplatin, etoposide \[RICE\], rituximab, cytarabine, dexamethasone, oxaliplatin or carboplatin RDHAP/X\] or gemcitabine and oxaliplatin…
Phase 2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Gene therapy trial hopes to slow duchenne muscular dystrophy in young boys
Disease control Recruiting nowThe purpose of the study is to evaluate the safety, tolerability, and efficacy of BBM-D101 to treat participants with Duchenne Muscular Dystrophy.
Phase 1/2 • Sponsor: Belief BioMed (Beijing) Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can a diabetes drug help people with type 1 diabetes lose weight?
Disease control Recruiting nowTirzepatide, a gut hormone-based medication, has shown promising results in treating obesity, with \~22% weight loss and mild side effects. However, patients with type 2 diabetes typically experience only about 15% weight loss with tirzepatide, despite tolerating the medication w…
Phase 4 • Sponsor: Dasman Diabetes Institute • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Blood test identifies relapse risk; targeted drug shows promise
Disease control By invitation onlyAfter an initial screening phase to identify patients with persistent blood circulating DNA tumors, patients will be enrolled in the treatment phase that was designed as an open-label, multicentre, phase II study, to test the efficacy of trastuzumab deruxtecan in terms of progres…
Phase 2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC